Free
In-App Purchases

Details

  • Released
  • Updated
  • August 31, 2026
  • September 5, 2026

Features

IQONIC screenshot #1 for iPhone
IQONIC screenshot #2 for iPhone
IQONIC screenshot #3 for iPhone
IQONIC screenshot #4 for iPhone
IQONIC screenshot #5 for iPhone
iphone
ipad
🖼️Get Icon
Icons↘︎

About

Track peptide research protocols with precision, manage compounds, doses, and schedules. Features a dosing calculator, spending tracker, and lifestyle logging. Integrates with Apple Health for a comprehensive health overview.

✓Custom protocol building
✓Dosing and reconstitution calculator
✓Spending and cost tracking
✓Apple Health integration
✓Compound library with detailed profiles
✓Adherence and consistency tracking
Show original description

What's New in IQONIC

1.2

September 5, 2026

• Start with a 3-day free trial • Cycle tracking, built for women running a protocol: log your cycle in seconds, see cycle length history, symptom patterns and body metrics on one timeline with your compounds, and export a clinician report. Stored privately on your device, never sold or shared. • New rose theme • Refreshed design across Stack, Profile, Calculator and Library • Clearer spending and supply tracking • Bug fixes and performance improvements

More

Subscription plans

Premium Annual

Full access to tracking, protocols & library.

$49.991 Year
3 Days trial
How to cancel IQONIC subscription ⁉️

User reviews

Amazing

I’ve been using IQONIC for a few months now and it’s become part of my routine. The spending tracker alone is worth it, I had no idea how much I was actually putting into this until I saw it laid out. Makes budgeting way easier.

What really sold me is the research side. Instead of digging through forums and sketchy sources, I can pull up compound info in one place and actually cross-check things before I commit to anything. The protocol tracking feature keeps everything logged so I’m not relying on memory or random notes on my phone.

It feels like it was built by people who actually understand what users in this space need, not just a generic tracker with a peptide label slapped on it. Smooth interface, no crashes, updates regularly.

Highly recommend!
Show more

Love

absolutely love this app because it helps and makes everything so clear for me to understand!

FAQ

What is IQONIC?

IQONIC is an organizational and educational tool designed to help users track peptide research protocols with precision. It assists with managing compounds, doses, schedules, and includes features for calculating doses and tracking expenses.

Does IQONIC provide medical advice?

No, IQONIC is strictly an organizational and educational tool. It does not provide medical advice, diagnosis, or treatment. Users should always consult a licensed healthcare professional for any health-related concerns.

How does IQONIC handle user data privacy?

IQONIC prioritizes user privacy and security. Your data is stored securely and is never sold or shared. Users can sign in using Apple, Google, or email.

What health metrics can IQONIC track?

IQONIC integrates with Apple Health to track steps and calories burned. It also allows for weight tracking with trend graphs, sleep tracking with weekly charts, nutrition logging via AI meal scanning or barcode lookup, and water intake monitoring.

What are the subscription options for IQONIC Premium?

IQONIC Premium is available as an auto-renewing subscription, with options for monthly or annual billing. Payments are charged to your Apple ID account, and subscriptions can be managed or canceled in your App Store account settings.

How often is IQONIC updated?

The latest version of IQONIC is 1.2, and it was last updated on September 5, 2026. Updates typically occur to improve features and reliability.

What devices are supported by IQONIC?

IQONIC is compatible with iPhone, iPad, and iPod devices. It is designed for iOS users looking for a comprehensive research and health tracking solution.

Is IQONIC suitable for users under 17?

IQONIC has an age rating of 17+, indicating it is intended for mature users. This is likely due to the nature of the research compounds discussed within the application.